Aug 13, 2026 04:17PM
Jul 21, 2026 08:03AM
Jul 17, 2026 04:21PM
Jul 13, 2026 05:14PM
Jun 18, 2026 09:01AM
May 7, 2026 08:31AM
Apr 21, 2026 06:09AM Cadrenal Therapeutics (CVKD) files for 1.18M share offering by selling stockholders
Apr 7, 2026 11:34AM
Mar 2, 2026 08:01AM
Jan 12, 2026 08:02AM
Dec 30, 2025 08:00AM
Dec 29, 2025 08:00AM
Dec 12, 2025 11:00AM
Dec 12, 2025 09:45AM Cadrenal adds VLX-1005 to anticoagulation pipeline
Dec 12, 2025 09:45AM
Nov 10, 2025 09:05AM
Sep 15, 2025 08:02AM
Aug 11, 2025 08:02AM
Aug 5, 2025 06:01AM
May 15, 2025 07:31AM
May 8, 2025 08:02AM Cadrenal Therapeutics, Inc. (CVKD) Reports Q1 Loss of $2.09
Mar 4, 2025 08:05AM
Feb 6, 2025 09:01AM
Nov 11, 2024 07:26AM
Oct 24, 2024 09:00AM
Sep 11, 2024 01:00PM
Sep 11, 2024 01:00PM
Aug 22, 2024 09:03AM Cadrenal Therapeutics (CVKD) Announces Upcoming Type-B FDA Meeting in September to Discuss Tecarfarin Trial in LVAD Patients
Aug 20, 2024 07:11AM

444,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All